CS91791A3 - Epithelium or epithelium precursors - Google Patents

Epithelium or epithelium precursors Download PDF

Info

Publication number
CS91791A3
CS91791A3 CS91917A CS91791A CS91791A3 CS 91791 A3 CS91791 A3 CS 91791A3 CS 91917 A CS91917 A CS 91917A CS 91791 A CS91791 A CS 91791A CS 91791 A3 CS91791 A3 CS 91791A3
Authority
CS
Czechoslovakia
Prior art keywords
epithelin
amino acid
chain
pharmaceutical composition
growth
Prior art date
Application number
CS91917A
Other languages
Czech (cs)
English (en)
Inventor
Mohammed Shoyab
Gregory D Plowman
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CS91791A3 publication Critical patent/CS91791A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS91917A 1990-04-03 1991-04-03 Epithelium or epithelium precursors CS91791A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50450890A 1990-04-03 1990-04-03
US07/668,648 US5416192A (en) 1990-04-03 1991-03-13 Epithelins: novel cysteine-rich growth modulating proteins

Publications (1)

Publication Number Publication Date
CS91791A3 true CS91791A3 (en) 1992-06-17

Family

ID=27054846

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91917A CS91791A3 (en) 1990-04-03 1991-04-03 Epithelium or epithelium precursors

Country Status (15)

Country Link
US (3) US5416192A (fr)
EP (1) EP0527806B1 (fr)
CN (1) CN1058782A (fr)
AT (1) ATE162549T1 (fr)
AU (1) AU639787B2 (fr)
CA (1) CA2079218A1 (fr)
CS (1) CS91791A3 (fr)
DE (1) DE69128779D1 (fr)
GR (1) GR3026263T3 (fr)
HU (1) HUT63438A (fr)
IE (1) IE911117A1 (fr)
IL (1) IL97758A0 (fr)
NZ (1) NZ237661A (fr)
OA (1) OA09711A (fr)
WO (1) WO1991015510A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1325792A (en) * 1992-02-03 1993-09-01 Samuel Solomon Granulins from leukocytes
WO2000055319A1 (fr) * 1999-03-12 2000-09-21 Genentech, Inc. Procedes et compositions pour inhiber la croissance des cellules neoplasiques
WO2000075316A1 (fr) * 1999-06-02 2000-12-14 Genentech, Inc. Procedes et compositions pour l'inhibition de la croissance de cellules neoplastiques
WO2001049715A2 (fr) * 2000-01-06 2001-07-12 Genentech, Inc. Methodes et compositions permettant d'inhiber la croissance cellulaire neoplasique
WO2000032778A2 (fr) * 1998-12-01 2000-06-08 Genentech, Inc. Methodes et compositions permettant d'inhiber la croissance de cellules neoplasiques
WO2000053751A1 (fr) * 1999-03-08 2000-09-14 Genentech, Inc. Procedes et compositions pour l'inhibition de la croissance de cellules neoplasiques
US6720159B1 (en) * 1997-12-16 2004-04-13 A&G Pharmaceutical, Inc. 88KDA tumorigenic growth factor and antagonists
US7091047B2 (en) * 1997-05-23 2006-08-15 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity
US6881548B2 (en) * 1997-05-23 2005-04-19 A&G Pharmaceutical, Inc. Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
US6309826B1 (en) * 1997-05-23 2001-10-30 Ginette Serrero 88kDa tumorigenic growth factor and antagonists
US20030215445A1 (en) 1997-05-23 2003-11-20 Ginette Serrero Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US20100111928A1 (en) * 1997-05-23 2010-05-06 A & G Pharmaceutical, Inc. Methods and kits for diagnosis tumorgenicity
US8512960B2 (en) * 1997-05-23 2013-08-20 A&G Pharmaceutical, Inc. 88kDa tumorigenic growth factor and antagonists
CA2344465A1 (fr) * 1998-10-13 2000-04-20 Genentech, Inc. Procedes et compositions inhibant la croissance des cellules neoplasiques
DK1484338T3 (da) * 1998-12-22 2007-06-11 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
CA2450402A1 (fr) * 1998-12-22 2000-06-29 Genentech, Inc. Methodes et compositions permettant d'inhiber la croissance de cellules cancereuses avec la pro224
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
EP1873244A3 (fr) * 1999-06-02 2008-04-02 Genentech, Inc. Procédés et compositions d'inhibition de la croissance de cellules néoplasiques
DK1185648T3 (da) * 1999-06-02 2007-07-30 Genentech Inc Fremgangsmåder og sammensætninger til inhibition af neoplastisk cellevækst
AU2001241877A1 (en) * 2000-02-28 2001-09-12 The Regents Of The University Of California Methods for detection and treatment of neural cancers
US6872703B2 (en) * 2000-06-07 2005-03-29 Ajinomoto Co., Inc. Insulin receptor-related receptor binding protein
AUPR673001A0 (en) * 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
WO2003074662A2 (fr) * 2002-03-01 2003-09-12 Exelixis, Inc. Enzymes scd utilisees comme modificateurs de la voie p53 et procedes d'utilisation correspondants
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
ATE483724T1 (de) * 2003-02-26 2010-10-15 A & G Pharmaceuticals Inc Verfahren zur erhöhung der ausbreitung von b- zellen
CA2530582C (fr) * 2003-06-23 2014-09-09 A&G Pharmaceutical, Inc. Compositions et procedes pour rendre a des cellules tumorales leur sensibilite a un traitement antitumoral et induire l'apoptose
WO2005009363A2 (fr) * 2003-07-21 2005-02-03 Medimmune, Inc. Traitements d'etats precancereux et prevention du cancer au moyen de therapies a base de pcdgf
ES2426916T3 (es) * 2003-08-01 2013-10-25 A & G Pharmaceutical, Inc. Composiciones y procedimientos para restaurar la sensibilidad al tratamiento con antagonistas de HER2
ES2624261T3 (es) 2008-09-05 2017-07-13 A & G Pharmaceutical, Inc. Procedimientos de diagnostico de cáncer y de determinación de la supervivencia global y la supervivencia sin enfermedad de pacientes con cáncer
CA2758542A1 (fr) 2009-04-17 2010-10-21 New York University Peptides ciblant les recepteurs de la famille du tnf et contrant l'action du tnf, compositions, methodes et utilisations afferentes
US9913399B2 (en) 2015-02-09 2018-03-06 Dell Products, Lp System and method for wireless rack management controller communication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590003A (en) * 1984-03-23 1986-05-20 Oncogen Platelet related growth regulator

Also Published As

Publication number Publication date
GR3026263T3 (en) 1998-05-29
HU9203137D0 (en) 1992-12-28
US5965723A (en) 1999-10-12
HUT63438A (en) 1993-08-30
OA09711A (en) 1993-08-30
EP0527806B1 (fr) 1998-01-21
IL97758A0 (en) 1992-06-21
ATE162549T1 (de) 1998-02-15
EP0527806A1 (fr) 1993-02-24
IE911117A1 (en) 1991-10-09
EP0527806A4 (en) 1993-05-05
DE69128779D1 (de) 1998-02-26
CN1058782A (zh) 1992-02-19
AU7744791A (en) 1991-10-30
NZ237661A (en) 1993-07-27
CA2079218A1 (fr) 1991-10-04
AU639787B2 (en) 1993-08-05
WO1991015510A1 (fr) 1991-10-17
US5416192A (en) 1995-05-16
US5885961A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
CS91791A3 (en) Epithelium or epithelium precursors
US5773252A (en) Fibroblast growth factor 15
US7439327B2 (en) Stem cell factor-like proteins and uses thereof
US20090118176A1 (en) Stem Cell Factor-Like Protein Scfa1 and Uses Thereof
JP2002533058A (ja) 97個のヒト分泌タンパク質
JP2001514885A (ja) 70個のヒト分泌タンパク質
JP2000508894A (ja) 細胞外/上皮増殖因子hcaba58x
JP2002505871A (ja) 31個のヒト分泌タンパク質
JPH11506917A (ja) 線維芽細胞増殖因子11
JP2001231578A (ja) Il−1ファミリーに属する蛋白質
JP2003521215A (ja) 83個のヒト分泌タンパク質
JPH11507504A (ja) 線維芽細胞増殖因子13
JPH10510518A (ja) ヒト血管ibp様成長因子
KR19990008319A (ko) 섬유아세포 성장 인자 15
JP2000508531A (ja) 細胞外/上皮増殖因子様タンパク質
JPH11506908A (ja) トランスフォーミング増殖因子αHII
JP2001517064A (ja) トランスフォーミング増殖因子アルファhi
AU2008201780B2 (en) Fibroblast growth factor-like polypeptides
JP2001505426A (ja) 線維芽細胞増殖因子13
KR100407087B1 (ko) 사람혈관성ibp-유사성장인자
CA2341326A1 (fr) Nouvelle proteine et son procede de production
US20020049304A1 (en) Human CCN-like growth factor
JP2002511743A (ja) 細胞外/上皮成長因子様タンパク質
AU752592B2 (en) Fibroblast growth factor 15
JP2005015460A (ja) Sgltホモログ用途